401 related articles for article (PubMed ID: 35604216)
1. The Attenuated Pseudorabies Virus Vaccine Strain Bartha Hyperactivates Plasmacytoid Dendritic Cells by Generating Large Amounts of Cell-Free Virus in Infected Epithelial Cells.
Delva JL; Van Waesberghe C; Van Den Broeck W; Lamote JA; Vereecke N; Theuns S; Couck L; Favoreel HW
J Virol; 2022 Jun; 96(12):e0219921. PubMed ID: 35604216
[TBL] [Abstract][Full Text] [Related]
2. The Pseudorabies Virus Glycoprotein gE/gI Complex Suppresses Type I Interferon Production by Plasmacytoid Dendritic Cells.
Lamote JAS; Kestens M; Van Waesberghe C; Delva J; De Pelsmaeker S; Devriendt B; Favoreel HW
J Virol; 2017 Apr; 91(7):. PubMed ID: 28122975
[TBL] [Abstract][Full Text] [Related]
3. Construction of a quadruple gene-deleted vaccine confers complete protective immunity against emerging PRV variant challenge in piglets.
Sun L; Tang Y; Yan K; Zhang H
Virol J; 2022 Jan; 19(1):19. PubMed ID: 35078501
[TBL] [Abstract][Full Text] [Related]
4. Proteomic Comparison of Three Wild-Type Pseudorabies Virus Strains and the Attenuated Bartha Strain Reveals Reduced Incorporation of Several Tegument Proteins in Bartha Virions.
Delva JL; Daled S; Van Waesberghe C; Almey R; Jansens RJJ; Deforce D; Dhaenens M; Favoreel HW
J Virol; 2022 Dec; 96(24):e0115822. PubMed ID: 36453884
[TBL] [Abstract][Full Text] [Related]
5. An inactivated gE-deleted pseudorabies vaccine provides complete clinical protection and reduces virus shedding against challenge by a Chinese pseudorabies variant.
Wang J; Guo R; Qiao Y; Xu M; Wang Z; Liu Y; Gu Y; Liu C; Hou J
BMC Vet Res; 2016 Dec; 12(1):277. PubMed ID: 27923365
[TBL] [Abstract][Full Text] [Related]
6. Effective cross-protection of a lyophilized live gE/gI/TK-deleted pseudorabies virus (PRV) vaccine against classical and variant PRV challenges.
Sun Y; Zhao L; Fu ZF
Vet Microbiol; 2022 Apr; 267():109387. PubMed ID: 35276621
[TBL] [Abstract][Full Text] [Related]
7. A novel inactivated gE/gI deleted pseudorabies virus (PRV) vaccine completely protects pigs from an emerged variant PRV challenge.
Gu Z; Dong J; Wang J; Hou C; Sun H; Yang W; Bai J; Jiang P
Virus Res; 2015 Jan; 195():57-63. PubMed ID: 25240533
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of an attenuated Chinese pseudorabies variant by dual deletion of TK&gE genes.
Wang J; Song Z; Ge A; Guo R; Qiao Y; Xu M; Wang Z; Liu Y; Zheng Y; Fan H; Hou J
BMC Vet Res; 2018 Sep; 14(1):287. PubMed ID: 30241529
[TBL] [Abstract][Full Text] [Related]
9. Recombinant pseudorabies virus with gI/gE deletion generated by overlapping polymerase chain reaction and homologous recombination technology induces protection against the PRV variant PRV-GD2013.
Li W; Zhuang D; Li H; Zhao M; Zhu E; Xie B; Chen J; Zhao M
BMC Vet Res; 2021 Apr; 17(1):164. PubMed ID: 33853597
[TBL] [Abstract][Full Text] [Related]
10. A novel gE-deleted pseudorabies virus (PRV) provides rapid and complete protection from lethal challenge with the PRV variant emerging in Bartha-K61-vaccinated swine population in China.
Wang CH; Yuan J; Qin HY; Luo Y; Cong X; Li Y; Chen J; Li S; Sun Y; Qiu HJ
Vaccine; 2014 Jun; 32(27):3379-85. PubMed ID: 24793946
[TBL] [Abstract][Full Text] [Related]
11. Pseudorabies virus variant in Bartha-K61-vaccinated pigs, China, 2012.
An TQ; Peng JM; Tian ZJ; Zhao HY; Li N; Liu YM; Chen JZ; Leng CL; Sun Y; Chang D; Tong GZ
Emerg Infect Dis; 2013 Nov; 19(11):1749-55. PubMed ID: 24188614
[TBL] [Abstract][Full Text] [Related]
12. Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs.
Wang Y; Yuan J; Cong X; Qin HY; Wang CH; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
Clin Vaccine Immunol; 2015 Oct; 22(10):1121-9. PubMed ID: 26311244
[TBL] [Abstract][Full Text] [Related]
13. Novel pseudorabies virus variant with defects in TK, gE and gI protects growing pigs against lethal challenge.
Hu RM; Zhou Q; Song WB; Sun EC; Zhang MM; He QG; Chen HC; Wu B; Liu ZF
Vaccine; 2015 Oct; 33(43):5733-5740. PubMed ID: 26428456
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine.
Mettenleiter TC; Klupp BG; Weiland F; Visser N
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1723-33. PubMed ID: 8021601
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a gE/gI/TK gene-deleted pseudorabies virus variant expressing the Cap protein of porcine circovirus type 2d.
Xu RQ; Wang LQ; Zheng HH; Tian RB; Zheng LL; Ma SJ; Chen HY
Comp Immunol Microbiol Infect Dis; 2023 Oct; 101():102054. PubMed ID: 37651789
[TBL] [Abstract][Full Text] [Related]
16. Emergence of a novel pathogenic recombinant virus from Bartha vaccine and variant pseudorabies virus in China.
Bo Z; Miao Y; Xi R; Gao X; Miao D; Chen H; Jung YS; Qian Y; Dai J
Transbound Emerg Dis; 2021 May; 68(3):1454-1464. PubMed ID: 32857916
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the Bartha-K61 vaccine and a gE
Wang J; Cui X; Wang X; Wang W; Gao S; Liu X; Kai Y; Chen C
Res Vet Sci; 2020 Feb; 128():16-23. PubMed ID: 31707096
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the protective efficacy between the candidate vaccine ZJ01R carrying gE/gI/TK deletion and three commercial vaccines against an emerging pseudorabies virus variant.
Jiang C; Ma Z; Bai J; Sun Y; Cao M; Wang X; Jiang P; Liu X
Vet Microbiol; 2023 Jan; 276():109623. PubMed ID: 36495739
[TBL] [Abstract][Full Text] [Related]
19. Characterization of changes in the short unique segment of pseudorabies virus BUK-TK900 (Suivac A) vaccine strain.
Ficińska J; Bieńkowska-Szewczyk K; Jacobs L; Płucienniczak G; Płucienniczak A; Szewczyk B
Arch Virol; 2003 Aug; 148(8):1593-612. PubMed ID: 12898333
[TBL] [Abstract][Full Text] [Related]
20. A live gI/gE-deleted pseudorabies virus (PRV) protects weaned piglets against lethal variant PRV challenge.
Yin Y; Xu Z; Liu X; Li P; Yang F; Zhao J; Fan Y; Sun X; Zhu L
Virus Genes; 2017 Aug; 53(4):565-572. PubMed ID: 28417300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
